Veeva Summit Europe: future-proofed AI set to bolster commercial pharma operations

Core Insights - The 2025 Veeva Commercial Summit Europe highlighted the significant role of AI in the pharma and life sciences industry, with executives discussing its evolving landscape and expressing excitement for its short-term and long-term potential [1][2] Group 1: AI Adoption and Implementation - The complexity and potential of AI have rapidly expanded, leading to widespread implementation across the life sciences industry to enhance efficiency [2] - Decision-makers are urged to identify the best use cases for AI in daily operations while acknowledging current pitfalls to ensure trust and accuracy [3] Group 2: Agentic AI - Agentic AI is emerging as a notable technology within the pharma sector, capable of autonomously performing tasks without human intervention [4] - Companies like Bayer are exploring the gradual adoption of agentic AI, with a focus on reducing manual workloads for administrative tasks [5] - There is a need for full trust in AI before granting it autonomy, with a preference for augmented AI as a preliminary step [6] Group 3: Integration and Future-Proofing - For agentic AI to be effective in life sciences, it must be deeply integrated into daily workflows rather than merely layered on top [6] - AI systems should be designed to be future-proof to keep pace with the rapid evolution of technology [7]